Your session is about to expire
← Back to Search
Procedure
Angel Cooler for Lung Disease
N/A
Waitlist Available
Led By Luis Angel
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age at least 18 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test a method of keeping the lungs cool during a specific period by monitoring temperature, oxygen levels, and ventilation. The lungs will be cooled to 4-8 degrees Celsius, with
Who is the study for?
This trial is for individuals with lung disease. Specific eligibility criteria are not provided, so it's important to contact the study organizers for detailed information on who can participate.
What is being tested?
The 'Angel Cooler' system is being tested to see if it can effectively monitor temperature and oxygen levels while keeping donated lungs cool and ventilated before transplant.
What are the potential side effects?
Since this trial involves a device rather than a drug, side effects may include potential complications related to lung preservation or transplantation procedures.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Proportion of Devices Deemed "Functional"
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Explanted LungsExperimental Treatment1 Intervention
After the lungs are explanted from the recipient donor, they will be connected to the "Angel Cooler" via a tracheostomy tube or special adaptor to assess the function of this device in providing cooling oxygen and positive pressure to keep the lungs inflated while on the back table. The lungs will be hooked up to the cooling machine for 15-20 minutes. During this time, investigators will monitor the airway temperature, pressure and oxygen concentration continuously during the entire preservation time. Once these measures are obtained and synced to a corresponding computer, investigators will then disconnect the lungs from the device and continue the standard procedure of sending them to pathology where they will be discarded per usual in lung transplantation.
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,409 Previous Clinical Trials
855,568 Total Patients Enrolled
Luis AngelPrincipal InvestigatorNYU Langone Health
Share this study with friends
Copy Link
Messenger